PFS in patients with multiple myeloma treated with auto/RIC allo or auto alone. PFS was significantly better for the auto/RICallo group: 33% vs 18% (P = .003) at 60 months and 22% vs 12% (P = .027) at 96 months. All patients included—ITT. Gray = auto/RICallo; black = auto.